Lysogene, a biopharmaceutical company specializing in gene therapies, announced on Monday the appointment of Côme de La Tour du Pin as CFO.

The executive had joined the company as VP Finance in 2020, before taking up the position of CFO 'ad interim' in November 2022.

In this role, he was involved in fundraising, investor relations and FP&A (controlling, reporting and financial analysis).

Prior to joining Lysogene, he had worked in investor relations at Ipsen, as well as within the Casino Group, following stints in investment banking at BNP Paribas and auditing at PwC.

He is to replace Stéphane Durant des Aulnois, who has decided to leave the company to pursue other opportunities.

Copyright (c) 2023 CercleFinance.com. All rights reserved.